The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Boehringer Ingelheim, a global leader in animal health, announced that the US Food and Drug Administration (FDA) has approved Vetmedin (pimobendan) chewable tablets and Vetmedin solution (pimobendan ...
Heart disease affects approximately 10 percent of dogs in their lifetime 1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results